IMPACT | Jotup

BUILDING HOPE TO HOST THIRD ANNUAL IMPACT SUMMIT AND AWARDS APRIL 23-25, 2024

Retrieved on:

목요일, 10월 5, 2023

School, Building Hope, Student, Grant, Performing, Education, Growth, IMPACT, Volunteering, Tourism

WASHINGTON, Oct. 5, 2023 /PRNewswire/ -- Building Hope, the non-profit leader in charter school facilities, financing, and services, today announced it will host the third annual IMPACT Summit & Awards on April 23-25, 2024, in Miami, Florida in Downtown Miami. $175,000 in grants will be awarded to charter schools that excel in community engagement, educational innovation, student empowerment and who are leaders in the charter school space.

Key Points:

The application window for the third annual IMPACT Awards opens October 23, 2023, and remains open until November 30.
"Building Hope is honored to host the 3rd Annual IMPACT Summit and Awards," said Building Hope President and CEO Bill Hansen.
"At the Building Hope IMPACT Summit, charter school leaders connect, collaborate and celebrate what is going right in education today," said Sherilyn Moore, Chief Impact Officer and IMPACT Awards Selection Committee Chair.
To learn more about the Building Hope IMPACT Summit and Awards or to apply for a grant, visit https://impactawards.buildinghope.org .

Leading Provider of School-based Services Launches New Platform to Transform Clinician Collaboration Around Student Needs

Retrieved on:

수요일, 9월 27, 2023

National Center for Trauma-Informed Care, School, Depression, National Center for Education Statistics, Anxiety, COVID-19, History, Student, EHR, Behavior, Mental, Case management, National Directorate for Personal Data Protection, Insight, Integration, Trauma, Mental health, Nursing, IMPACT

"As clinicians face unprecedented caseloads in schools today, there's an urgency to ensure practitioners have the right data, in real-time. Few, if any, EHR platforms have been specifically designed for services in the school setting-- leaving clinicians and behavioral health professionals to navigate a web of systems to capture and manage the data and case management details that are essential to the delivering successful outcomes. We're streamlining the process so clinicians can focus on meeting the unique needs of each student," said Matt Stringer, CEO of Invo Healthcare. "Insight not only supports collaboration between clinical teams, it provides district leaders valuable insights into the impact of their mental health programs so they can target supports where the need is most urgent."

Key Points:

Built for the unique delivery of services in schools, the platform is an integrated workspace for clinicians and district leaders working with Invo's multidisciplinary behavioral and mental health focused programs.
The platform is being rolled out as schools report record numbers of behavioral and mental health challenges among students.
We're streamlining the process so clinicians can focus on meeting the unique needs of each student," said Matt Stringer, CEO of Invo Healthcare.
This unique model leverages multi-disciplinary teams like board certified behavior analysts, mental health clinicians, and behavior support professionals to meet students' needs.

DIVINE NINE PRESIDENTS VISIT RICHARD WRIGHT SCHOOLS, CONTRIBUTE $10,000, AND PLEDGE TO CONTINUE SUPPORT

Retrieved on:

화요일, 9월 26, 2023

WASHINGTON, Sept. 26, 2023 /PRNewswire/ -- Over 300 Richard Wright Schools students bore witness to what an inclusive and intentional sisterhood and brotherhood invested in their success looks like today as the Council of Presidents of the National Pan-Hellenic Council (NPHC), composed of the historically Black Greek-lettered member organizations, affectionately known as "The Divine Nine," visited the school and contributed $10,000 to support the school's growth.

Key Points:

Divine Nine presidents visit Richard Wright Schools, contribute $10,000, and pledge to continue support
Founded in 2010, Richard Wright School transforms lives in an engaging, student-centered environment with a caring, highly qualified staff to develop students for college and beyond.
During this historic visit, each of the Divine Nine leaders was interviewed by one of the student anchors from the Wright Now News Network (WNN)@richardwightschools.
Here at the Richard Wright School, I am excited because there is an intentional vision about the power of possibility.
Richard Wright Schools is preparing to renovate and expand its current facility in partnership with DC-based nonprofit Building Hope.

Billy Beane, EVP of the Oakland A’s and Pioneer of Moneyball, and Annie Duke, Author and Former Professional Poker Player, to Headline Monte Carlo’s Data Observability Summit

Retrieved on:

화요일, 9월 19, 2023

Today, Monte Carlo , the data observability leader, announced its keynote speakers for IMPACT: The Data Observability Summit, its annual virtual conference taking place November 8, 2023.

Key Points:

Today, Monte Carlo , the data observability leader, announced its keynote speakers for IMPACT: The Data Observability Summit, its annual virtual conference taking place November 8, 2023.
Duke is a World Series of Poker gold bracelet winner and a top-five leading money winner among women in WSOP history.
The company has driven and led the G2 category for data observability two quarters in a row, and achieved leader status in the GigaOM Radar for Data Observability.
IMPACT 2023 will be the third iteration of Monte Carlo’s marquee event and the world’s first conference dedicated to data observability.

White House Highlights The Leukemia & Lymphoma Society's Efforts to Bring Clinical Trials and Treatment Innovation to Diverse and Underrepresented Communities Nationwide in Alignment with the Biden-Harris Administration's Cancer Moonshot

Retrieved on:

목요일, 9월 14, 2023

RYE BROOK, N.Y., Sept. 14, 2023 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the largest nonprofit dedicated to creating a world without blood cancers, is proud to be recognized by the White House Cancer Moonshot for its investment and efforts to promote health equity in the latest Cancer Moonshot Fact Sheet released yesterday by the White House.

Key Points:

The Leukemia & Lymphoma Society is making major investments in solutions to advance equitable access to cancer care.
From the White House Fact Sheet:
The Leukemia & Lymphoma Society (LLS) will invest more than $17 million to bring clinical trials and treatment innovation to diverse and underrepresented communities across the country.
For example, LLS is expanding its Influential Medicine Providing Access to Clinical Trials (IMPACT) Research Grant Program to include seven major, geographically diverse cancer centers and surrounding local cancer care delivery settings, to bring blood cancer treatment studies into more communities.
Through the Influential Medicine Providing Access to Clinical Trials (IMPACT) program, LLS seeks to bring clinical trials to patients.

Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia

Retrieved on:

목요일, 9월 7, 2023

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces that it has received approval from the US FDA for its IND application for one Phase 2b/3 clinical study of S-pindolol benzoate (the “IMPACT” clinical trial programme) to treat cachexia associated with colorectal cancer (IMPACT CRC) and another in patients with non-small cell lung cancer (IMPACT NSCLC).

Key Points:

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces that it has received approval from the US FDA for its IND application for one Phase 2b/3 clinical study of S-pindolol benzoate (the “IMPACT” clinical trial programme) to treat cachexia associated with colorectal cancer (IMPACT CRC) and another in patients with non-small cell lung cancer (IMPACT NSCLC).
Cachexia has long been recognised as a secondary disease to cancer can lead to up to 20% of cancer deaths.
The anti-catabolic and pro-anabolic pharmacology of S-pindolol benzoate position it as a novel and promising new therapy for cancer cachexia.
WG Partners, a London-based Life Sciences specialist advisory firm, is assisting Actimed in the Series B financing which is now well advanced.

Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures

Retrieved on:

목요일, 9월 14, 2023

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.

Key Points:

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
View the full release here: https://www.businesswire.com/news/home/20230914650329/en/
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
It is the most common type of cardiac ablation procedure, with over 300,000 per year performed in the US alone.
This De Novo marketing authorization expands the ensoETM’s indications for use to reduce the likelihood of esophageal injury resulting from radiofrequency cardiac ablation procedures.

Physician's Weekly Maximizes Advertising Effectiveness Through Data Driven Insights Derived from Proprietary IMPACT Data Platform

Retrieved on:

수요일, 9월 13, 2023

Advertising, Intelligence, Social, HCP, DE, Patient, IMPACT, Artificial intelligence, POC, Health

The IMPACT platform is a new powerful data engine that ensures pharmaceutical brands can maximize PW's unique dual reach to HCPs and patients at the POC.

Key Points:

The IMPACT platform is a new powerful data engine that ensures pharmaceutical brands can maximize PW's unique dual reach to HCPs and patients at the POC.
The technology helps brands identify and quantify strategically relevant HCPs, patients, or both in PW's networks using the company's first-party data, claims data, and real-world medical events.
Through PW's focus on the data platform, the number of successful use cases across brands' lifecycles and specialties continues to grow.
For example, the IMPACT platform can benchmark competitive sets for brands to craft and deploy relevant messaging.

Wemade launches new Block Explorer 'WEMIX Scan'

Retrieved on:

수요일, 9월 6, 2023

Partnership, USD, NCP, IMPACT, Cryptocurrency, Ethereum

SEOUL, South Korea, Sept. 6, 2023 /PRNewswire/ -- Leading South Korea-based blockchain developer Wemade has officially launched WEMIX Scan, the new block explorer of its WEMIX3.0 Mainnet and testnet.

Key Points:

SEOUL, South Korea, Sept. 6, 2023 /PRNewswire/ -- Leading South Korea-based blockchain developer Wemade has officially launched WEMIX Scan, the new block explorer of its WEMIX3.0 Mainnet and testnet.
Wemade signed a partnership with Etherscan last May for the development of a block explorer for Wemix3.0 mainnet and Ethereum layer 2 project 'Kroma'.
Kroma's block explorer is currently being developed and will be released later.
Etherscan, the main block explorer of Ethereum, offers features to explore and check all the blocks, transactions, and contract addresses within the Ethereum blockchain.

Wemade launches new Block Explorer 'WEMIX Scan'

Retrieved on:

수요일, 9월 6, 2023

Partnership, USD, NCP, IMPACT, Cryptocurrency, Ethereum

SEOUL, South Korea, Sept. 6, 2023 /PRNewswire/ -- Leading South Korea-based blockchain developer Wemade has officially launched WEMIX Scan, the new block explorer of its WEMIX3.0 Mainnet and testnet.

Key Points:

SEOUL, South Korea, Sept. 6, 2023 /PRNewswire/ -- Leading South Korea-based blockchain developer Wemade has officially launched WEMIX Scan, the new block explorer of its WEMIX3.0 Mainnet and testnet.
Wemade signed a partnership with Etherscan last May for the development of a block explorer for Wemix3.0 mainnet and Ethereum layer 2 project 'Kroma'.
Kroma's block explorer is currently being developed and will be released later.
Etherscan, the main block explorer of Ethereum, offers features to explore and check all the blocks, transactions, and contract addresses within the Ethereum blockchain.